| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 82 | 2026 | 760 | 14.640 |
Why?
|
| Genetic Vectors | 73 | 2026 | 930 | 12.820 |
Why?
|
| Genetic Therapy | 61 | 2026 | 852 | 8.260 |
Why?
|
| Transduction, Genetic | 19 | 2026 | 242 | 4.380 |
Why?
|
| Gene Transfer Techniques | 26 | 2025 | 325 | 4.120 |
Why?
|
| Central Nervous System | 10 | 2023 | 205 | 2.640 |
Why?
|
| MicroRNAs | 14 | 2026 | 714 | 2.540 |
Why?
|
| Capsid Proteins | 7 | 2026 | 107 | 2.030 |
Why?
|
| Canavan Disease | 4 | 2023 | 11 | 2.020 |
Why?
|
| Animals | 97 | 2026 | 21493 | 1.880 |
Why?
|
| Mice | 78 | 2026 | 11185 | 1.850 |
Why?
|
| Gene Editing | 13 | 2025 | 331 | 1.750 |
Why?
|
| Transgenes | 14 | 2026 | 207 | 1.680 |
Why?
|
| CRISPR-Cas Systems | 10 | 2025 | 369 | 1.260 |
Why?
|
| Capsid | 5 | 2026 | 104 | 1.240 |
Why?
|
| Disease Models, Animal | 28 | 2026 | 2329 | 1.060 |
Why?
|
| Humans | 84 | 2026 | 65845 | 1.050 |
Why?
|
| Gene Silencing | 6 | 2026 | 439 | 1.000 |
Why?
|
| Amidohydrolases | 3 | 2016 | 36 | 0.950 |
Why?
|
| Macular Degeneration | 2 | 2026 | 196 | 0.900 |
Why?
|
| Genome, Viral | 7 | 2024 | 145 | 0.900 |
Why?
|
| Liver | 14 | 2026 | 875 | 0.890 |
Why?
|
| Blood-Brain Barrier | 2 | 2018 | 99 | 0.840 |
Why?
|
| Mice, Inbred C57BL | 18 | 2026 | 3506 | 0.820 |
Why?
|
| Prostatic Neoplasms | 2 | 2021 | 504 | 0.810 |
Why?
|
| Recombinant Proteins | 4 | 2025 | 710 | 0.790 |
Why?
|
| Recombination, Genetic | 5 | 2025 | 256 | 0.750 |
Why?
|
| Liver Neoplasms | 3 | 2026 | 310 | 0.740 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2026 | 175 | 0.730 |
Why?
|
| Serogroup | 4 | 2020 | 35 | 0.690 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2021 | 11 | 0.670 |
Why?
|
| Gene Expression | 3 | 2019 | 856 | 0.670 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2021 | 13 | 0.670 |
Why?
|
| Sialyltransferases | 1 | 2021 | 21 | 0.660 |
Why?
|
| Lentivirus | 1 | 2021 | 64 | 0.650 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2020 | 23 | 0.650 |
Why?
|
| Communicable Diseases | 1 | 2021 | 86 | 0.640 |
Why?
|
| Spinal Cord | 2 | 2018 | 210 | 0.620 |
Why?
|
| DNA, Viral | 2 | 2020 | 232 | 0.620 |
Why?
|
| Epilepsy | 1 | 2021 | 113 | 0.610 |
Why?
|
| Myocardium | 2 | 2013 | 302 | 0.610 |
Why?
|
| Nervous System Diseases | 2 | 2024 | 109 | 0.600 |
Why?
|
| Influenza Vaccines | 1 | 2020 | 100 | 0.590 |
Why?
|
| Prostate | 2 | 2021 | 123 | 0.590 |
Why?
|
| Antigen Presentation | 1 | 2021 | 239 | 0.580 |
Why?
|
| Colposcopy | 1 | 2019 | 20 | 0.570 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2019 | 29 | 0.570 |
Why?
|
| Papillomaviridae | 1 | 2019 | 59 | 0.560 |
Why?
|
| Immunotherapy | 1 | 2021 | 274 | 0.560 |
Why?
|
| Adenoviridae | 4 | 2022 | 132 | 0.560 |
Why?
|
| Genes, Recessive | 1 | 2018 | 51 | 0.560 |
Why?
|
| Infusions, Spinal | 1 | 2018 | 3 | 0.550 |
Why?
|
| Alleles | 2 | 2021 | 455 | 0.540 |
Why?
|
| Heterozygote | 1 | 2018 | 175 | 0.540 |
Why?
|
| Transfection | 5 | 2025 | 700 | 0.540 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 206 | 0.520 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 220 | 0.520 |
Why?
|
| Inverted Repeat Sequences | 1 | 2017 | 14 | 0.510 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2019 | 155 | 0.510 |
Why?
|
| Osteoporosis | 3 | 2024 | 113 | 0.510 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 134 | 0.510 |
Why?
|
| Retina | 3 | 2026 | 135 | 0.500 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 588 | 0.500 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2017 | 35 | 0.500 |
Why?
|
| Ornithine Carbamoyltransferase | 2 | 2013 | 4 | 0.490 |
Why?
|
| Lung | 5 | 2024 | 969 | 0.480 |
Why?
|
| SMN Complex Proteins | 1 | 2016 | 6 | 0.470 |
Why?
|
| Mutation | 6 | 2025 | 2675 | 0.470 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2026 | 517 | 0.470 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 2 | 2026 | 13 | 0.460 |
Why?
|
| Pandemics | 1 | 2020 | 691 | 0.460 |
Why?
|
| Neoplasms | 3 | 2021 | 1378 | 0.450 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 327 | 0.450 |
Why?
|
| Maple Syrup Urine Disease | 2 | 2026 | 24 | 0.450 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 60 | 0.440 |
Why?
|
| Muscular Atrophy, Spinal | 2 | 2026 | 25 | 0.430 |
Why?
|
| Clinical Trials as Topic | 4 | 2024 | 462 | 0.420 |
Why?
|
| Bone Diseases | 2 | 2024 | 25 | 0.410 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2013 | 2 | 0.400 |
Why?
|
| Mice, Transgenic | 10 | 2026 | 1292 | 0.400 |
Why?
|
| Mucopolysaccharidosis VII | 1 | 2013 | 2 | 0.390 |
Why?
|
| Vitreoretinopathy, Proliferative | 1 | 2013 | 3 | 0.390 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2013 | 6 | 0.390 |
Why?
|
| Myositis Ossificans | 2 | 2023 | 7 | 0.390 |
Why?
|
| Male | 22 | 2026 | 31410 | 0.390 |
Why?
|
| Macaca mulatta | 3 | 2024 | 263 | 0.380 |
Why?
|
| Vitreous Body | 1 | 2013 | 31 | 0.380 |
Why?
|
| Organ Specificity | 7 | 2025 | 201 | 0.380 |
Why?
|
| Muscles | 1 | 2014 | 179 | 0.380 |
Why?
|
| Virus Cultivation | 1 | 2012 | 18 | 0.370 |
Why?
|
| Indoles | 1 | 2013 | 112 | 0.370 |
Why?
|
| Gene Expression Regulation | 4 | 2025 | 1635 | 0.360 |
Why?
|
| Cell Line | 7 | 2019 | 2031 | 0.360 |
Why?
|
| HEK293 Cells | 7 | 2025 | 617 | 0.350 |
Why?
|
| Neurons | 4 | 2018 | 935 | 0.350 |
Why?
|
| Genes, Reporter | 5 | 2018 | 257 | 0.340 |
Why?
|
| Astrocytes | 2 | 2013 | 123 | 0.340 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 1573 | 0.340 |
Why?
|
| alpha 1-Antitrypsin | 2 | 2025 | 91 | 0.340 |
Why?
|
| Bone Resorption | 2 | 2023 | 46 | 0.340 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 2 | 2025 | 70 | 0.330 |
Why?
|
| Promoter Regions, Genetic | 5 | 2026 | 690 | 0.330 |
Why?
|
| Genetic Engineering | 4 | 2019 | 114 | 0.320 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2025 | 347 | 0.320 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 290 | 0.310 |
Why?
|
| Hepatocytes | 6 | 2026 | 226 | 0.310 |
Why?
|
| Phenotype | 3 | 2024 | 1236 | 0.310 |
Why?
|
| Green Fluorescent Proteins | 6 | 2018 | 372 | 0.300 |
Why?
|
| Aspartic Acid | 2 | 2023 | 34 | 0.290 |
Why?
|
| DNA-Binding Proteins | 4 | 2023 | 1226 | 0.280 |
Why?
|
| Huntingtin Protein | 3 | 2018 | 151 | 0.280 |
Why?
|
| Osteogenesis | 6 | 2026 | 154 | 0.270 |
Why?
|
| Bone and Bones | 4 | 2024 | 152 | 0.270 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2024 | 441 | 0.270 |
Why?
|
| Fibroblast Growth Factors | 2 | 2020 | 77 | 0.260 |
Why?
|
| Nucleic Acid Conformation | 2 | 2019 | 241 | 0.260 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 789 | 0.250 |
Why?
|
| Superoxide Dismutase-1 | 2 | 2026 | 148 | 0.250 |
Why?
|
| Plasmids | 3 | 2023 | 294 | 0.250 |
Why?
|
| Mice, Knockout | 4 | 2026 | 2168 | 0.250 |
Why?
|
| Activin Receptors, Type I | 2 | 2023 | 15 | 0.250 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2026 | 234 | 0.240 |
Why?
|
| Dopaminergic Neurons | 2 | 2019 | 37 | 0.240 |
Why?
|
| Protein Phosphatase 1 | 1 | 2026 | 19 | 0.240 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2026 | 12 | 0.240 |
Why?
|
| Interferon-beta | 2 | 2017 | 79 | 0.240 |
Why?
|
| Chondrocytes | 1 | 2026 | 45 | 0.240 |
Why?
|
| RNA, Transfer | 2 | 2024 | 93 | 0.240 |
Why?
|
| Female | 13 | 2026 | 34425 | 0.230 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2026 | 53 | 0.230 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2025 | 29 | 0.230 |
Why?
|
| Brain | 6 | 2026 | 1672 | 0.230 |
Why?
|
| RNA Precursors | 1 | 2026 | 80 | 0.230 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2018 | 94 | 0.230 |
Why?
|
| DNA, Circular | 1 | 2025 | 7 | 0.220 |
Why?
|
| Liver Failure, Acute | 1 | 2025 | 25 | 0.220 |
Why?
|
| RNA, Small Interfering | 4 | 2023 | 993 | 0.220 |
Why?
|
| Osteoblasts | 5 | 2026 | 204 | 0.220 |
Why?
|
| Codon, Nonsense | 2 | 2024 | 62 | 0.220 |
Why?
|
| Superoxide Dismutase | 2 | 2017 | 223 | 0.220 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2019 | 211 | 0.220 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2025 | 5 | 0.220 |
Why?
|
| Alternative Splicing | 1 | 2026 | 140 | 0.220 |
Why?
|
| Interleukin-1 | 1 | 2025 | 154 | 0.220 |
Why?
|
| Acetaminophen | 1 | 2025 | 53 | 0.220 |
Why?
|
| Ubiquinone | 1 | 2025 | 22 | 0.220 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2025 | 53 | 0.220 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2024 | 4 | 0.220 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2024 | 7 | 0.220 |
Why?
|
| Glioblastoma | 2 | 2017 | 161 | 0.220 |
Why?
|
| Binding Sites | 2 | 2021 | 922 | 0.210 |
Why?
|
| Codon | 1 | 2025 | 60 | 0.210 |
Why?
|
| Alveolar Bone Loss | 1 | 2024 | 4 | 0.210 |
Why?
|
| Eye Diseases | 1 | 2024 | 37 | 0.210 |
Why?
|
| Lipid Metabolism | 1 | 2026 | 227 | 0.210 |
Why?
|
| Recombinational DNA Repair | 2 | 2021 | 29 | 0.210 |
Why?
|
| Retinal Diseases | 1 | 2024 | 34 | 0.210 |
Why?
|
| Adaptive Immunity | 1 | 2025 | 105 | 0.210 |
Why?
|
| Inflammation | 4 | 2025 | 1198 | 0.200 |
Why?
|
| Liver Diseases | 1 | 2025 | 157 | 0.200 |
Why?
|
| Stress, Physiological | 1 | 2026 | 210 | 0.200 |
Why?
|
| Adenine | 1 | 2024 | 48 | 0.200 |
Why?
|
| Lung Diseases | 1 | 2025 | 183 | 0.200 |
Why?
|
| RNA Interference | 2 | 2019 | 647 | 0.200 |
Why?
|
| Cholesterol | 2 | 2017 | 262 | 0.200 |
Why?
|
| Brain Neoplasms | 2 | 2017 | 323 | 0.190 |
Why?
|
| Oligodendroglia | 1 | 2023 | 41 | 0.190 |
Why?
|
| Myelin Sheath | 1 | 2023 | 39 | 0.190 |
Why?
|
| Microglia | 3 | 2024 | 254 | 0.190 |
Why?
|
| Nanopores | 1 | 2022 | 14 | 0.190 |
Why?
|
| Ossification, Heterotopic | 1 | 2022 | 14 | 0.190 |
Why?
|
| Oxidative Phosphorylation | 1 | 2022 | 44 | 0.190 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2022 | 22 | 0.180 |
Why?
|
| Protein Biosynthesis | 1 | 2025 | 333 | 0.180 |
Why?
|
| Homeostasis | 1 | 2025 | 383 | 0.180 |
Why?
|
| Down-Regulation | 2 | 2021 | 326 | 0.180 |
Why?
|
| Osteocytes | 1 | 2022 | 14 | 0.180 |
Why?
|
| Animals, Newborn | 2 | 2013 | 241 | 0.180 |
Why?
|
| Sirtuin 1 | 1 | 2022 | 27 | 0.180 |
Why?
|
| Lipogenesis | 1 | 2022 | 66 | 0.180 |
Why?
|
| Cell Lineage | 1 | 2023 | 282 | 0.180 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 10 | 0.170 |
Why?
|
| Tyrosinemias | 1 | 2021 | 20 | 0.170 |
Why?
|
| Mammals | 1 | 2023 | 222 | 0.170 |
Why?
|
| Signal Transduction | 5 | 2026 | 3170 | 0.170 |
Why?
|
| Retinal Vasculitis | 1 | 2021 | 9 | 0.170 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 316 | 0.170 |
Why?
|
| Neostriatum | 2 | 2018 | 26 | 0.170 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 31 | 0.170 |
Why?
|
| Fractures, Bone | 1 | 2022 | 138 | 0.170 |
Why?
|
| Choroidal Neovascularization | 1 | 2021 | 28 | 0.170 |
Why?
|
| Gene Order | 2 | 2019 | 33 | 0.170 |
Why?
|
| Frontotemporal Dementia | 1 | 2023 | 158 | 0.170 |
Why?
|
| Autocrine Communication | 1 | 2020 | 30 | 0.160 |
Why?
|
| Immunity, Innate | 2 | 2025 | 829 | 0.160 |
Why?
|
| Precision Medicine | 1 | 2022 | 134 | 0.160 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 333 | 0.160 |
Why?
|
| Stem Cells | 1 | 2022 | 278 | 0.160 |
Why?
|
| Antigen-Presenting Cells | 1 | 2021 | 180 | 0.160 |
Why?
|
| Virus Assembly | 1 | 2020 | 54 | 0.160 |
Why?
|
| T-Lymphocytes | 1 | 2025 | 1012 | 0.160 |
Why?
|
| Carcinogenesis | 1 | 2021 | 135 | 0.150 |
Why?
|
| Vaccines | 1 | 2021 | 97 | 0.150 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 408 | 0.150 |
Why?
|
| Complement C3 | 1 | 2019 | 61 | 0.150 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 60 | 0.150 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2018 | 100 | 0.150 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2022 | 38 | 0.150 |
Why?
|
| Thalamus | 1 | 2019 | 78 | 0.150 |
Why?
|
| RNA Stability | 1 | 2019 | 104 | 0.140 |
Why?
|
| Models, Biological | 2 | 2017 | 1193 | 0.140 |
Why?
|
| Phylogeny | 1 | 2020 | 400 | 0.140 |
Why?
|
| Base Sequence | 2 | 2012 | 1332 | 0.140 |
Why?
|
| Callithrix | 2 | 2019 | 21 | 0.140 |
Why?
|
| Corpus Striatum | 1 | 2019 | 99 | 0.140 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2019 | 42 | 0.140 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 80 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 182 | 0.140 |
Why?
|
| RNA, Untranslated | 1 | 2019 | 105 | 0.140 |
Why?
|
| Cocaine | 1 | 2019 | 101 | 0.140 |
Why?
|
| DNA End-Joining Repair | 2 | 2018 | 26 | 0.140 |
Why?
|
| RNA, Viral | 1 | 2019 | 267 | 0.140 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2018 | 6 | 0.140 |
Why?
|
| Infusions, Intraventricular | 1 | 2018 | 12 | 0.140 |
Why?
|
| Primates | 2 | 2018 | 52 | 0.140 |
Why?
|
| Osmotic Pressure | 1 | 2018 | 17 | 0.140 |
Why?
|
| China | 1 | 2019 | 181 | 0.140 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 193 | 0.140 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 218 | 0.140 |
Why?
|
| Adipose Tissue | 1 | 2020 | 301 | 0.140 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1980 | 0.130 |
Why?
|
| Caudate Nucleus | 1 | 2018 | 25 | 0.130 |
Why?
|
| Putamen | 1 | 2018 | 21 | 0.130 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 29 | 0.130 |
Why?
|
| Synapses | 1 | 2019 | 195 | 0.130 |
Why?
|
| Viral Load | 1 | 2019 | 230 | 0.130 |
Why?
|
| Catheters, Indwelling | 1 | 2018 | 67 | 0.130 |
Why?
|
| Mutant Proteins | 1 | 2018 | 105 | 0.130 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2017 | 4 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2019 | 216 | 0.130 |
Why?
|
| Rod Cell Outer Segment | 1 | 2017 | 8 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 2 | 2020 | 235 | 0.130 |
Why?
|
| Foam Cells | 1 | 2017 | 5 | 0.130 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2017 | 8 | 0.130 |
Why?
|
| Lipofuscin | 1 | 2017 | 5 | 0.130 |
Why?
|
| Retinal Degeneration | 1 | 2017 | 28 | 0.130 |
Why?
|
| Biological Transport | 1 | 2018 | 292 | 0.130 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2017 | 27 | 0.130 |
Why?
|
| Virus Internalization | 1 | 2018 | 91 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 95 | 0.130 |
Why?
|
| Multiple Sclerosis | 1 | 2019 | 227 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1044 | 0.130 |
Why?
|
| Sequence Deletion | 1 | 2017 | 115 | 0.120 |
Why?
|
| Phosphorylation | 3 | 2026 | 963 | 0.120 |
Why?
|
| Embryonic Development | 1 | 2018 | 142 | 0.120 |
Why?
|
| Rural Population | 1 | 2019 | 225 | 0.120 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 134 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 2017 | 116 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2019 | 2194 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 220 | 0.120 |
Why?
|
| Huntington Disease | 1 | 2018 | 164 | 0.120 |
Why?
|
| DNA | 2 | 2024 | 853 | 0.120 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2017 | 93 | 0.120 |
Why?
|
| Serotyping | 1 | 2015 | 52 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 417 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 286 | 0.110 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 167 | 0.110 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2015 | 63 | 0.110 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 103 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 738 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 119 | 0.110 |
Why?
|
| Habenula | 1 | 2015 | 14 | 0.110 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2015 | 38 | 0.110 |
Why?
|
| DNA Replication | 1 | 2017 | 250 | 0.110 |
Why?
|
| Interpeduncular Nucleus | 1 | 2015 | 21 | 0.110 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2015 | 87 | 0.110 |
Why?
|
| Ventral Tegmental Area | 1 | 2015 | 38 | 0.110 |
Why?
|
| Targeted Gene Repair | 1 | 2014 | 3 | 0.110 |
Why?
|
| Endonucleases | 3 | 2023 | 84 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2016 | 579 | 0.110 |
Why?
|
| Autophagy | 1 | 2017 | 240 | 0.110 |
Why?
|
| HeLa Cells | 2 | 2021 | 541 | 0.110 |
Why?
|
| RNA Editing | 1 | 2014 | 27 | 0.110 |
Why?
|
| PPAR alpha | 1 | 2014 | 33 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2022 | 827 | 0.100 |
Why?
|
| Prognosis | 1 | 2019 | 1793 | 0.100 |
Why?
|
| Nicotine | 1 | 2015 | 118 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 206 | 0.100 |
Why?
|
| Mesencephalon | 1 | 2013 | 28 | 0.100 |
Why?
|
| Motor Neurons | 2 | 2026 | 219 | 0.100 |
Why?
|
| Memory, Long-Term | 1 | 2013 | 7 | 0.100 |
Why?
|
| Ribonuclease III | 1 | 2013 | 86 | 0.100 |
Why?
|
| Iodide Peroxidase | 1 | 2013 | 23 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 178 | 0.100 |
Why?
|
| X-Ray Diffraction | 1 | 2013 | 62 | 0.100 |
Why?
|
| Histone Deacetylase 1 | 1 | 2013 | 19 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2013 | 160 | 0.100 |
Why?
|
| Research Subjects | 1 | 2013 | 40 | 0.100 |
Why?
|
| Virus Integration | 1 | 2013 | 33 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2500 | 0.100 |
Why?
|
| Exploratory Behavior | 1 | 2013 | 36 | 0.100 |
Why?
|
| RNA Splicing | 1 | 2014 | 173 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 97 | 0.100 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2014 | 154 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 134 | 0.090 |
Why?
|
| Cell Differentiation | 3 | 2026 | 1391 | 0.090 |
Why?
|
| Memory, Short-Term | 1 | 2013 | 67 | 0.090 |
Why?
|
| Containment of Biohazards | 1 | 2012 | 6 | 0.090 |
Why?
|
| Ultracentrifugation | 1 | 2012 | 28 | 0.090 |
Why?
|
| Middle Aged | 4 | 2019 | 18501 | 0.090 |
Why?
|
| Rabbits | 1 | 2013 | 342 | 0.090 |
Why?
|
| Prefrontal Cortex | 1 | 2013 | 129 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 157 | 0.090 |
Why?
|
| RNA, Antisense | 1 | 2012 | 51 | 0.090 |
Why?
|
| Anxiety | 1 | 2015 | 427 | 0.090 |
Why?
|
| Peptides | 1 | 2015 | 593 | 0.090 |
Why?
|
| Oligonucleotides | 2 | 2024 | 229 | 0.090 |
Why?
|
| Cell Division | 1 | 2013 | 451 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 2739 | 0.090 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2011 | 16 | 0.080 |
Why?
|
| Random Allocation | 1 | 2011 | 200 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2013 | 423 | 0.080 |
Why?
|
| Virus Replication | 1 | 2012 | 323 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 899 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2010 | 302 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2026 | 503 | 0.080 |
Why?
|
| Gyrus Cinguli | 1 | 2010 | 61 | 0.080 |
Why?
|
| Terminal Repeat Sequences | 2 | 2022 | 13 | 0.080 |
Why?
|
| Vero Cells | 1 | 2009 | 81 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2017 | 1561 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 514 | 0.070 |
Why?
|
| Biotechnology | 1 | 2009 | 38 | 0.070 |
Why?
|
| Intravitreal Injections | 2 | 2021 | 55 | 0.070 |
Why?
|
| Rats | 1 | 2013 | 2005 | 0.070 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2020 | 46 | 0.070 |
Why?
|
| Adult | 3 | 2022 | 17579 | 0.070 |
Why?
|
| Sheep | 2 | 2018 | 194 | 0.060 |
Why?
|
| Animals, Genetically Modified | 2 | 2018 | 312 | 0.060 |
Why?
|
| Injections | 2 | 2018 | 84 | 0.060 |
Why?
|
| Chondrogenesis | 1 | 2026 | 11 | 0.060 |
Why?
|
| Growth Plate | 1 | 2026 | 14 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2026 | 15 | 0.060 |
Why?
|
| Cricetulus | 2 | 2017 | 104 | 0.060 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2026 | 10 | 0.060 |
Why?
|
| CHO Cells | 2 | 2017 | 193 | 0.060 |
Why?
|
| Heart Failure | 1 | 2014 | 968 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2017 | 287 | 0.060 |
Why?
|
| Administration, Intravenous | 1 | 2026 | 78 | 0.060 |
Why?
|
| Locomotion | 2 | 2019 | 111 | 0.060 |
Why?
|
| Metabolomics | 1 | 2026 | 64 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2019 | 312 | 0.060 |
Why?
|
| Neuromuscular Junction | 1 | 2026 | 83 | 0.060 |
Why?
|
| Ferrets | 1 | 2025 | 11 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2026 | 86 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2025 | 15 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2025 | 38 | 0.060 |
Why?
|
| Exons | 1 | 2026 | 208 | 0.060 |
Why?
|
| Succinate Dehydrogenase | 1 | 2025 | 16 | 0.060 |
Why?
|
| Fumarates | 1 | 2025 | 10 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5834 | 0.050 |
Why?
|
| Electron Transport | 1 | 2025 | 30 | 0.050 |
Why?
|
| Electrons | 1 | 2025 | 33 | 0.050 |
Why?
|
| Aged | 3 | 2019 | 15147 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2025 | 79 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2026 | 277 | 0.050 |
Why?
|
| Insulin Resistance | 2 | 2020 | 415 | 0.050 |
Why?
|
| Cattle | 1 | 2025 | 320 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2017 | 377 | 0.050 |
Why?
|
| Hypoxia | 1 | 2025 | 121 | 0.050 |
Why?
|
| Technology | 1 | 2023 | 53 | 0.050 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 87 | 0.050 |
Why?
|
| Macaca fascicularis | 1 | 2023 | 48 | 0.050 |
Why?
|
| Activins | 1 | 2023 | 55 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 292 | 0.050 |
Why?
|
| Oxygen | 1 | 2025 | 323 | 0.050 |
Why?
|
| Osteoclasts | 1 | 2023 | 53 | 0.050 |
Why?
|
| Dipeptides | 1 | 2023 | 69 | 0.050 |
Why?
|
| DNA Repeat Expansion | 1 | 2023 | 59 | 0.050 |
Why?
|
| beta Catenin | 1 | 2023 | 100 | 0.050 |
Why?
|
| Malonyl Coenzyme A | 1 | 2022 | 11 | 0.050 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2022 | 9 | 0.050 |
Why?
|
| Palmitates | 1 | 2022 | 20 | 0.050 |
Why?
|
| Acetyl Coenzyme A | 1 | 2022 | 24 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2026 | 364 | 0.050 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2022 | 17 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2022 | 80 | 0.050 |
Why?
|
| Baculoviridae | 1 | 2022 | 24 | 0.050 |
Why?
|
| C9orf72 Protein | 1 | 2023 | 115 | 0.050 |
Why?
|
| Insecta | 1 | 2022 | 36 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2022 | 23 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2022 | 87 | 0.040 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2022 | 26 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2022 | 45 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 92 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2018 | 1583 | 0.040 |
Why?
|
| Proteomics | 1 | 2023 | 299 | 0.040 |
Why?
|
| Bacterial Proteins | 2 | 2018 | 741 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 416 | 0.040 |
Why?
|
| Endocrine System | 1 | 2020 | 16 | 0.040 |
Why?
|
| Adiponectin | 1 | 2020 | 37 | 0.040 |
Why?
|
| Apoptosis | 2 | 2018 | 1100 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 301 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2020 | 59 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2021 | 83 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2022 | 323 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 427 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2023 | 332 | 0.040 |
Why?
|
| Receptors, Complement 3b | 1 | 2019 | 12 | 0.040 |
Why?
|
| Gliosis | 1 | 2019 | 27 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2019 | 62 | 0.040 |
Why?
|
| Algorithms | 1 | 2025 | 1060 | 0.040 |
Why?
|
| Cartilage | 1 | 2019 | 35 | 0.040 |
Why?
|
| Infant | 1 | 2024 | 1718 | 0.040 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2018 | 11 | 0.030 |
Why?
|
| Workflow | 1 | 2019 | 77 | 0.030 |
Why?
|
| Adipocytes | 1 | 2020 | 276 | 0.030 |
Why?
|
| Wool | 1 | 2018 | 5 | 0.030 |
Why?
|
| Fallopian Tubes | 1 | 2018 | 13 | 0.030 |
Why?
|
| Sheep, Domestic | 1 | 2018 | 13 | 0.030 |
Why?
|
| Electrolytes | 1 | 2018 | 26 | 0.030 |
Why?
|
| Internal Capsule | 1 | 2018 | 11 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2017 | 10 | 0.030 |
Why?
|
| Immunoassay | 1 | 2018 | 71 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2020 | 400 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 30 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2017 | 44 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2017 | 42 | 0.030 |
Why?
|
| Proteins | 1 | 2023 | 764 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 869 | 0.030 |
Why?
|
| Injections, Intraocular | 1 | 2017 | 5 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 252 | 0.030 |
Why?
|
| Obesity | 2 | 2017 | 1281 | 0.030 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2017 | 9 | 0.030 |
Why?
|
| Blastocyst | 1 | 2018 | 74 | 0.030 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2017 | 16 | 0.030 |
Why?
|
| CD36 Antigens | 1 | 2017 | 26 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2017 | 38 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 369 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2017 | 48 | 0.030 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 34 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1719 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 115 | 0.030 |
Why?
|
| Fluorescence | 1 | 2017 | 93 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2017 | 77 | 0.030 |
Why?
|
| Sirolimus | 1 | 2017 | 93 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2017 | 83 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 2017 | 94 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 203 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2017 | 204 | 0.030 |
Why?
|
| Lysosomes | 1 | 2017 | 176 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 377 | 0.030 |
Why?
|
| Cellular Microenvironment | 1 | 2015 | 23 | 0.030 |
Why?
|
| Cilia | 1 | 2017 | 156 | 0.030 |
Why?
|
| Cats | 1 | 2015 | 92 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1172 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 274 | 0.030 |
Why?
|
| Kidney | 1 | 2018 | 460 | 0.030 |
Why?
|
| Lidocaine | 1 | 2015 | 33 | 0.030 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2015 | 27 | 0.030 |
Why?
|
| Punctures | 1 | 2015 | 63 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2015 | 72 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 404 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1148 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 859 | 0.030 |
Why?
|
| Nerve Net | 1 | 2015 | 105 | 0.030 |
Why?
|
| Amphetamine | 1 | 2013 | 12 | 0.030 |
Why?
|
| Dopamine Agonists | 1 | 2013 | 22 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2015 | 126 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 465 | 0.020 |
Why?
|
| Stereotyped Behavior | 1 | 2013 | 9 | 0.020 |
Why?
|
| Haloperidol | 1 | 2013 | 17 | 0.020 |
Why?
|
| Genes, MHC Class II | 1 | 2013 | 36 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 279 | 0.020 |
Why?
|
| Clozapine | 1 | 2013 | 32 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 181 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2017 | 352 | 0.020 |
Why?
|
| Electroporation | 1 | 2013 | 36 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 179 | 0.020 |
Why?
|
| Learning | 1 | 2013 | 186 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 663 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 2401 | 0.020 |
Why?
|
| Transcriptome | 1 | 2013 | 408 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5682 | 0.020 |
Why?
|
| United States | 1 | 2022 | 8189 | 0.020 |
Why?
|